King's College London

Research portal

Value of schizophrenia treatment I: The patient journey

Research output: Contribution to journalArticle

Standard

Value of schizophrenia treatment I : The patient journey. / Mohr, Pavel; Galderisi, Silvana; Boyer, Patrice; Wasserman, Danuta; Arteel, Paul; Ieven, Aagje; Karkkainen, Hilkka; Pereira, Eulalia; Guldemond, Nick; Winkler, Petr; Gaebel, Wolfgang.

In: European Psychiatry, Vol. 53, 2018, p. 107-115.

Research output: Contribution to journalArticle

Harvard

Mohr, P, Galderisi, S, Boyer, P, Wasserman, D, Arteel, P, Ieven, A, Karkkainen, H, Pereira, E, Guldemond, N, Winkler, P & Gaebel, W 2018, 'Value of schizophrenia treatment I: The patient journey', European Psychiatry, vol. 53, pp. 107-115. https://doi.org/10.1016/j.eurpsy.2018.06.007

APA

Mohr, P., Galderisi, S., Boyer, P., Wasserman, D., Arteel, P., Ieven, A., Karkkainen, H., Pereira, E., Guldemond, N., Winkler, P., & Gaebel, W. (2018). Value of schizophrenia treatment I: The patient journey. European Psychiatry, 53, 107-115. https://doi.org/10.1016/j.eurpsy.2018.06.007

Vancouver

Mohr P, Galderisi S, Boyer P, Wasserman D, Arteel P, Ieven A et al. Value of schizophrenia treatment I: The patient journey. European Psychiatry. 2018;53:107-115. https://doi.org/10.1016/j.eurpsy.2018.06.007

Author

Mohr, Pavel ; Galderisi, Silvana ; Boyer, Patrice ; Wasserman, Danuta ; Arteel, Paul ; Ieven, Aagje ; Karkkainen, Hilkka ; Pereira, Eulalia ; Guldemond, Nick ; Winkler, Petr ; Gaebel, Wolfgang. / Value of schizophrenia treatment I : The patient journey. In: European Psychiatry. 2018 ; Vol. 53. pp. 107-115.

Bibtex Download

@article{12adc66dfd564e93bc4dc0027efe4f68,
title = "Value of schizophrenia treatment I: The patient journey",
abstract = "BackgroundThe aim of the European Brain Council project “The Value of Treatment” was to provide evidence-based, cost-effective policy recommendations for a patient-centered and sustainable coordinated care model for brain disorders. The first part of schizophrenia study examined the needs and gaps in the patients' care pathway.MethodsDescriptive analysis was based on an inventory of needs and treatment opportunities, using focus group sessions, expert interviews, users{\textquoteright} input, and literature review. Three patient pathways were selected: indicated prevention, duration of untreated psychosis, and relapse prevention.ResultsThe analysis identified several critical barriers to optimal treatment. Available health care services often miss or delay detection of symptoms and diagnosis in at-risk individuals. There is a lack of illness awareness among patients, families, and the public; scarcity of information, training and education among primary care providers; stigmatizing beliefs. Early symptom recognition and timely intervention result in better outcome and prognosis; effective management leads to a functional recovery. In the current model of care, there is insufficient cooperation between health and social care providers, patients and families, inadequate utilization of pharmacological and psychosocial interventions, lacking patient monitoring, and low implementation of integrated community care.ConclusionsEarly detection and early intervention programs, timely intervention, and relapse prevention are essential for effective management of schizophrenia. It requires a paradigm shift from symptom control, achieving and maintaining remission, to the emphasis on recovery. Since the current services are not able to accomplish this goal, changes in mental health policies are needed.",
keywords = "Schizophrenia, Patient journey, Prevention, Treatment, Recovery, Mental health",
author = "Pavel Mohr and Silvana Galderisi and Patrice Boyer and Danuta Wasserman and Paul Arteel and Aagje Ieven and Hilkka Karkkainen and Eulalia Pereira and Nick Guldemond and Petr Winkler and Wolfgang Gaebel",
year = "2018",
doi = "10.1016/j.eurpsy.2018.06.007",
language = "English",
volume = "53",
pages = "107--115",
journal = "European Psychiatry",
issn = "0924-9338",
publisher = "Elsevier B.V.",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Value of schizophrenia treatment I

T2 - The patient journey

AU - Mohr, Pavel

AU - Galderisi, Silvana

AU - Boyer, Patrice

AU - Wasserman, Danuta

AU - Arteel, Paul

AU - Ieven, Aagje

AU - Karkkainen, Hilkka

AU - Pereira, Eulalia

AU - Guldemond, Nick

AU - Winkler, Petr

AU - Gaebel, Wolfgang

PY - 2018

Y1 - 2018

N2 - BackgroundThe aim of the European Brain Council project “The Value of Treatment” was to provide evidence-based, cost-effective policy recommendations for a patient-centered and sustainable coordinated care model for brain disorders. The first part of schizophrenia study examined the needs and gaps in the patients' care pathway.MethodsDescriptive analysis was based on an inventory of needs and treatment opportunities, using focus group sessions, expert interviews, users’ input, and literature review. Three patient pathways were selected: indicated prevention, duration of untreated psychosis, and relapse prevention.ResultsThe analysis identified several critical barriers to optimal treatment. Available health care services often miss or delay detection of symptoms and diagnosis in at-risk individuals. There is a lack of illness awareness among patients, families, and the public; scarcity of information, training and education among primary care providers; stigmatizing beliefs. Early symptom recognition and timely intervention result in better outcome and prognosis; effective management leads to a functional recovery. In the current model of care, there is insufficient cooperation between health and social care providers, patients and families, inadequate utilization of pharmacological and psychosocial interventions, lacking patient monitoring, and low implementation of integrated community care.ConclusionsEarly detection and early intervention programs, timely intervention, and relapse prevention are essential for effective management of schizophrenia. It requires a paradigm shift from symptom control, achieving and maintaining remission, to the emphasis on recovery. Since the current services are not able to accomplish this goal, changes in mental health policies are needed.

AB - BackgroundThe aim of the European Brain Council project “The Value of Treatment” was to provide evidence-based, cost-effective policy recommendations for a patient-centered and sustainable coordinated care model for brain disorders. The first part of schizophrenia study examined the needs and gaps in the patients' care pathway.MethodsDescriptive analysis was based on an inventory of needs and treatment opportunities, using focus group sessions, expert interviews, users’ input, and literature review. Three patient pathways were selected: indicated prevention, duration of untreated psychosis, and relapse prevention.ResultsThe analysis identified several critical barriers to optimal treatment. Available health care services often miss or delay detection of symptoms and diagnosis in at-risk individuals. There is a lack of illness awareness among patients, families, and the public; scarcity of information, training and education among primary care providers; stigmatizing beliefs. Early symptom recognition and timely intervention result in better outcome and prognosis; effective management leads to a functional recovery. In the current model of care, there is insufficient cooperation between health and social care providers, patients and families, inadequate utilization of pharmacological and psychosocial interventions, lacking patient monitoring, and low implementation of integrated community care.ConclusionsEarly detection and early intervention programs, timely intervention, and relapse prevention are essential for effective management of schizophrenia. It requires a paradigm shift from symptom control, achieving and maintaining remission, to the emphasis on recovery. Since the current services are not able to accomplish this goal, changes in mental health policies are needed.

KW - Schizophrenia

KW - Patient journey

KW - Prevention

KW - Treatment

KW - Recovery

KW - Mental health

U2 - 10.1016/j.eurpsy.2018.06.007

DO - 10.1016/j.eurpsy.2018.06.007

M3 - Article

VL - 53

SP - 107

EP - 115

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454